Table 4.

Treatment details of the study cohort.

Study Cohort (n = 158)	Median (Interquatile Range) or Number (Percentage)
Intravenous tissue-type plasminogen activator (IV tPA)	51 (32.28%)
Mechanical thrombectomy (MT)	130 (82.28%)
Admission NIH Stroke Scale	15 (10–20)
Premorbid Modified Rankin Score (mRS)
0	100 (65.79%)
1	20 (13.16%)
2	11 (7.24%)
3	19 (12.50%)
4	1 (0.66%)
5	1 (0.66%)
Modified treatment in cerebral infarction (mTICI)
0	6 (4.96%)
1	1 (0.83%)
2A	4 (3.31%)
2B	27 (22.31%)
2C	17 (14.05%)
3	66 (54.55%)

rCBV < 42% lesion volume and follow-up infarct volume.